Therapeutics. Review: tiotropium does not increase risk for cardiovascular events in chronic obstructive pulmonary disease.
Stanbrook
Matthew B
MB
University Health Network, University of Toronto, Toronto, Ontario, Canada. bcelli@cchcs.org